Groupe Hospitalier De La Region De Mulhouse Et Sud Alsace

Mulhouse 79 trials 46 recruiting

79 Registered trials

46 Currently recruiting

Organisation

Groupe Hospitalier De La Region De Mulhouse Et Sud Alsace

Location

Mulhouse, France

Identifier

ORG-100040766

Address

87 Avenue D Altkirch, 68100, France

Departments

Clinical trials at this site (79)

Search interface

A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended

2022-501418-69-00 Acute Coronary Syndrome 5 2023-11-21
LAMSA2020: “A phase II randomized study to assess the efficacy on outcome of Venetoclax combined with Cytarabine versus Idarubicin combined… Ended

2022-502392-37-00 elderly patients (> = 60 years) with Acute Myeloid Leuk 4 2022-05-25
A dual-cohort, open-label, phase 2 study of brentuximab vedotin and CHP (A+CHP) in the frontline treatment of subjects with peripheral T-cel… Ended

2023-509155-14-00 Peripheral T-cell Lymphoma 4 2021-06-10
European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial (SolidAct) Ended

2022-500385-99-00 SARS-CoV II infection (Coronavirus disease) 5 2021-06-03
IFCT-1802 SAVIMMUNE: Immunotherapy in Patient With Poor General Condition Ended

2024-515943-44-00 Non small cell lung cancer 4 2020-10-14
Trial comparing the continuation of nivolumab and ipilimumab (doublet immunotherapy) to observation after a first 6 months treatment by nivo… Ended

2024-514586-20-01 Non small cell lung cancer 5 2018-05-02
A Phase III Prospective Double Blind Placebo Controlled Randomized Study of Adjuvant MEDI4736 in Completely Resected Non-Small Cell Lung Can… Ended

2024-517856-36-00 Completely resected primary stage IB (≥ 4cm), II and II 5 2015-03-09